Several studies indicate that, in individuals infected with herpes simplex virus and/or varicella zoster virus, antiviral therapy reduces the subsequent risk of Alzheimer disease and other types of dementia. As highlighted in this article, the preventative potential of antiviral therapy would probably be maximized by treating asymptomatic as well as symptomatic infected individuals.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Aging Clinical and Experimental Research Open Access 09 May 2023
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Tsai, M. C. et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS One 12, e0188490 (2017).
Tzeng, N. S. et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections — a nationwide, population-based cohort study in Taiwan. Neurotherapeutics 15, 417–429 (2018).
Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry 79, 16m11312 (2018).
Itzhaki, R. F. et al. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 349, 241–244 (1997).
Itzhaki, R. F. Overwhelming evidence for a major role for herpes simplex virus type 1 (HSV1) in Alzheimer’s disease (AD); underwhelming evidence against. Vaccines 9, 679 (2021).
Bae, S. et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur. Arch. Psychiatry Clin. Neurosci. 271, 987–997 (2021).
Schnier, C. et al. Antiherpetic medication and incident dementia: observational cohort studies in four countries. Eur. J. Neurol. 28, 1840–1848 (2021).
Lopatko Lindman, K. et al. Herpesvirus infections, antiviral treatment, and the risk of dementia — a registry-based cohort study in Sweden. Alzheimers Dement. 7, e12119 (2021).
Young-Xu, Y. et al. Symptomatic herpes simplex virus infection and risk of dementia in US veterans: a cohort study. Neurotherapeutics https://doi.org/10.1007/s13311-021-01084-9 (2021).
Hemmingsson, E. S. et al. Antiviral treatment associated with reduced risk of clinical Alzheimer’s disease — a nested case-control study. Alzheimers Dement. 7, e12187 (2021).
The author thanks the Advantage Foundation for financial support.
The author declares no competing interests.
About this article
Cite this article
Itzhaki, R.F. Does antiherpetic antiviral therapy reduce the risk of dementia?. Nat Rev Neurol 18, 63–64 (2022). https://doi.org/10.1038/s41582-021-00596-4
This article is cited by
Aging Clinical and Experimental Research (2023)